Core Laboratories N.V. (CLB)
12.62
0.30 (2.44%)
At close: Apr 17, 2025, 3:59 PM
12.51
-0.86%
After-hours: Apr 17, 2025, 08:00 PM EDT
Core Laboratories Revenue Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product Revenue | 35.55M | 34.24M | 34.62M | 37.28M | 38.63M | 38.08M | 35.48M | 30.58M | 35.86M | 33.16M | 32.48M | 24.4M | 24.55M | 19.13M | 24.73M | 42.43M | 41.61M | 52.38M | 51.16M | 48.86M |
| Product Revenue Growth | +3.84% | -1.09% | -7.15% | -3.50% | +1.47% | +7.33% | +16.02% | -14.74% | +8.13% | +2.10% | +33.12% | -0.62% | +28.34% | -22.63% | -41.73% | +1.97% | -20.56% | +2.38% | +4.72% | n/a |
| Service Revenue | 98.84M | 96.34M | 93.27M | 91.08M | 88.94M | 87.89M | 85.42M | 84.72M | 89.28M | 84.82M | 86.26M | 83.98M | 89.19M | 86.25M | 91.01M | 109.97M | 115.16M | 120.82M | 117.87M | 120.34M |
| Service Revenue Growth | +2.60% | +3.29% | +2.40% | +2.40% | +1.19% | +2.89% | +0.83% | -5.10% | +5.25% | -1.67% | +2.72% | -5.84% | +3.41% | -5.23% | -17.24% | -4.51% | -4.68% | +2.50% | -2.05% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Countries Revenue | 323.03M | 322.07M | 328.33M | 353.8M | 342.14M | 342.53M | 347.33M | 414.81M | 464.33M | 445.57M | 374.49M | 351.76M |
| Other Countries Revenue Growth | +0.30% | -1.91% | -7.20% | +3.41% | -0.11% | -1.38% | -16.27% | -10.67% | +4.21% | +18.98% | +6.46% | n/a |
| United States Revenue | 166.7M | 148.18M | 158.94M | 289.17M | 324.07M | 284.26M | 224.86M | 338.91M | 515.64M | n/a | n/a | n/a |
| United States Revenue Growth | +12.50% | -6.77% | -45.04% | -10.77% | +14.01% | +26.41% | -33.65% | -34.27% | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 9.08M | 8.33M | 10.26M | 11.79M | 8.66M | 9.45M | 5.81M | 16.33M | 8.72M | 10M | 6.85M | 12.54M | 10.93M | 15.12M | 9.67M | 8.46M | -3.69M | 8.94M | 9.22M | 19.57M | 9.77M | 11.01M | 9.8M | 17.44M | 24.72M | 13.28M | 12.2M | 12.71M | 11.99M | 11.89M | 11.1M | 12.76M | 8.79M | 8.41M | 11.14M | 11.05M | 12.27M | 12.15M | 12.63M | 12.67M |
| Selling, General, and Administrative Revenue Growth | +9.03% | -18.82% | -12.98% | +36.05% | -8.33% | +62.66% | -64.42% | +87.20% | -12.77% | +46.06% | -45.42% | +14.81% | -27.71% | +56.31% | +14.29% | -329.17% | -141.31% | -3.08% | -52.87% | +100.21% | -11.25% | +12.36% | -43.79% | -29.46% | +86.18% | +8.82% | -3.99% | +5.96% | +0.90% | +7.09% | -12.98% | +45.04% | +4.63% | -24.54% | +0.81% | -9.91% | +0.91% | -3.79% | -0.32% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |